Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
IXJ
113
HOLDINGS
8%
ALSO IN OZEM
OZEM
22
HOLDINGS
41%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.6% | 16.2% | 9.6% |
 |
ASTRAZENECA PLC | 4.2% | 3.9% | 3.9% |
|
AMGEN INC | 2.5% | 3.9% | 2.5% |
|
PFIZER INC | 2.0% | 7.1% | 2.0% |
|
GILEAD SCIENCES INC | 2.3% | 1.9% | 1.9% |
IXJ Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 7.4% |
|
ABBVIE INC | 4.7% |
|
MERCK & CO. INC. | 4.0% |
 |
NOVARTIS AG | 3.9% |
|
UNITEDHEALTH GROUP INC | 3.6% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
ABBOTT LABORATORIES | 2.3% |
|
INTUITIVE SURGICAL INC | 2.1% |
 |
NOVO NORDISK A/S-B | 1.6% |
|
GSK PLC | 1.6% |
IXJ Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -13.2% |
|
ELI LILLY & CO | -6.6% |
|
VIKING THERAPEUTICS, INC. | -5.5% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
|
PFIZER INC | -5.1% |
 |
ASCLETIS PHARMA, INC. | -5.0% |
 |
HANMI PHARM CO LTD | -3.6% |
|
ZEALAND PHARMA A/S | -3.5% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.0% |